Zobrazeno 1 - 8
of 8
pro vyhledávání: '"I. Petrukh"'
Publikováno v:
Біологічні студії, Vol 10, Iss 1, Pp 53-60 (2016)
The effect of flurenizide (antibiotic of antimicrobial, antituberculousis, antichlamydia, immunomodulator, antioxidant, hepatoprotective, antiinflammatory, antiviral action) on the intensity of lipid peroxidation processes of embryos Misgurnus foss
Externí odkaz:
https://doaj.org/article/186fcda457d84b919929f945184532c3
Publikováno v:
The Animal Biology. 22:53-56
The Laboratory of molecular biology and clinical biochemistry was established with the foundation of Scientific Production Center (SPC) for the study of prion infections in 2001. SPC for the study of prion infections was founded by orders of the Ukra
Autor:
L. Kalynovska, I. Pavlyuk, V. V. Vlizlo, O. Shkilnyk, D. D. Ostapiv, M.P. Kozak, S. Ponomarjova, O. Vezdenko, O. Sekh, I. Petrukh
Publikováno v:
Scientific and Technical Bulletin оf State Scientific Research Control Institute of Veterinary Medical Products and Fodder Additives аnd Institute of Animal Biology. 21:247-251
The article describes the study of mineral metabolism in patients with cow ketosis and during feeding of our developed feed additive, which includes crushed hop cones, vitamin E and protected from cleavage in the rumen amino acids ˗ methionine, chol
Autor:
V. V. Vlizlo, V. Stybel, Biotechnologies named after S. Z. Gzhytsky, Pekarska str., Lviv , Ukraine, I. Petrukh, M. Simonov
Publikováno v:
The Animal Biology. 21:74-78
Publikováno v:
The Animal Biology. 18:9-17
Publikováno v:
Likars'ka sprava. (1)
Positive dynamics was observed in clinical picture and laboratory tests with sensitive to flureniside originators of pyelonephritis. No side effects were noted. The results obtained permit regarding flureniside as a drug of choice to be used for etio
Autor:
I H, Il'nyts'kyĭ, O V, Panasiuk, L I, Petrukh, M V, Hud', Ia H, Buts', V I, Mykhal'chuk, U B, Chulovs'ka, Iu O, Kozubs'kyĭ, O E, Lychkovs'kyĭ, A S, Hel'ner
Publikováno v:
Likars'ka sprava. (9-12)
Flurenizide, a new home drug preparation, endowed with antituberculosis activity, was administered to 20 patients with freshly detected pulmonary tuberculosis, in combination with etambutole or rifampycin in a daily dose of 0.6 g. After the above che
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.